> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Makary Defends CBER’s Prasad After Loomer Attack
- URL: https://www.fdaweb.com/makary-defends-cbers-prasad-after-loomer-attack/
- Published: 2025-07-25T12:00:00.000Z
- Updated: 2026-09-14T15:17:34.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5159570

FDA commissioner **Marty Makary** has defended CBER director **Vinay Prasad** from an online attack by far-right influencer and Trump confidant **Laura Loomer** in which she called for his removal for being too left-wing. In an interview with [*Politico*](https://www.politico.com/news/2025/07/25/fda-commissioner-mifepristone-abortion-00475294?ref=fdaweb.com), Makary said Prasad does not have a “political bone” in his body. 

Loomer [criticized](https://www.fdaweb.com/laura-loomer-urges-ouster-of-cber-head-prasad/) what she called Prasad’s lifelong progressive ideology and his past anti-Trump stance. She cited Prasad’s alleged advocacy for liberal policies like single-payer healthcare, student loan forgiveness, open borders, wealth taxes, and affirmative action. Additionally, she alleged that under Prasad’s leadership, FDA has missed multiple user fee deadlines and delayed approvals of gene and cell therapies without transparent justification. She argued that these actions contradict Trump’s mission to accelerate drug approvals and eliminate bureaucratic delays.

“He’s an impeccable scientist,” Makary told Politico. He also dismissed the attacks on Prasad and the agency more broadly as being driven by increased scrutiny of conservatives. “Usually when a Republican nominee or a conservative is in office, then there’s a level of scrutiny that you just don’t see in prior administrations,” he said.